Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Sexually Transmitted Disease (STD ) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sexually Transmitted Disease (STD ) Drugmarket, defines the market attractiveness level of Sexually Transmitted Disease (STD ) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sexually Transmitted Disease (STD ) Drug industry, describes the types of Sexually Transmitted Disease (STD ) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sexually Transmitted Disease (STD ) Drug market and the development prospects and opportunities of Sexually Transmitted Disease (STD ) Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sexually Transmitted Disease (STD ) Drug market in Chapter 13.
By Player:
Bristol-Myers Squibb
Roche
Gilead Sciences
AbbVie
Johnson & Johnson
Pfizer
GlaxoSmithKline
Merck
Eli Lilly
Bayer
By Type:
Antibiotics
Antiviral
Vaccines
By End-User:
Hospital
Clinic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sexually Transmitted Disease (STD ) Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sexually Transmitted Disease (STD ) Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sexually Transmitted Disease (STD ) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sexually Transmitted Disease (STD ) Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sexually Transmitted Disease (STD ) Drug Market Analysis and Outlook to 2022
-
7.1 Global Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.2 United States Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.3 Europe Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.4 China Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.5 Japan Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.6 India Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
-
7.7 South Korea Sexually Transmitted Disease (STD ) Drug Consumption (2017-2022)
8 Region and Country-wise Sexually Transmitted Disease (STD ) Drug Market Analysis and Outlook to 2028
-
8.1 Global Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.2 United States Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.3 Europe Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.4 China Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.5 Japan Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.6 India Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Sexually Transmitted Disease (STD ) Drug Consumption Forecast (2022-2028)
9 Global Sexually Transmitted Disease (STD ) Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antibiotics Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antiviral Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.2 Global Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
10 Global Sexually Transmitted Disease (STD ) Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
11 Global Sexually Transmitted Disease (STD ) Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sexually Transmitted Disease (STD ) Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sexually Transmitted Disease (STD ) Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sexually Transmitted Disease (STD ) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sexually Transmitted Disease (STD ) Drug Market Competitive Analysis
-
14.1 Bristol-Myers Squibb
-
14.1.1 Bristol-Myers Squibb Company Details
-
14.1.2 Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.3 Gilead Sciences
-
14.3.1 Gilead Sciences Company Details
-
14.3.2 Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Gilead Sciences Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.8 Merck
-
14.8.1 Merck Company Details
-
14.8.2 Merck Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly Sexually Transmitted Disease (STD ) Drug Product and Service
-
14.10 Bayer
-
14.10.1 Bayer Company Details
-
14.10.2 Bayer Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Bayer Sexually Transmitted Disease (STD ) Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sexually Transmitted Disease (STD ) Drug
-
Figure Sexually Transmitted Disease (STD ) Drug Picture
-
Table Global Sexually Transmitted Disease (STD ) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexually Transmitted Disease (STD ) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sexually Transmitted Disease (STD ) Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sexually Transmitted Disease (STD ) Drug Consumption by Country (2017-2022)
-
Figure United States Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Figure China Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Figure India Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sexually Transmitted Disease (STD ) Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Sexually Transmitted Disease (STD ) Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sexually Transmitted Disease (STD ) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibiotics Consumption and Growth Rate (2017-2022)
-
Figure Global Antiviral Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Antibiotics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiviral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sexually Transmitted Disease (STD ) Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sexually Transmitted Disease (STD ) Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Sexually Transmitted Disease (STD ) Drug Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Sexually Transmitted Disease (STD ) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Sexually Transmitted Disease (STD ) Drug Product and Service
-
